“Clinical Safety and Pharmacokinetics of FMX101 4% Topical Minocycline Foam in Pediatric Patients for the Treatment of Moderate-to-Severe Acne Vulgaris” (2019) SKIN The Journal of Cutaneous Medicine, 3, p. S2. doi:10.25251/skin.3.supp.2.